DK3713940T3 - Substituerede azacykler som muscarin-m1-receptorpositive allosteriske modulatorer - Google Patents
Substituerede azacykler som muscarin-m1-receptorpositive allosteriske modulatorer Download PDFInfo
- Publication number
- DK3713940T3 DK3713940T3 DK18822142.8T DK18822142T DK3713940T3 DK 3713940 T3 DK3713940 T3 DK 3713940T3 DK 18822142 T DK18822142 T DK 18822142T DK 3713940 T3 DK3713940 T3 DK 3713940T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptorpositive
- muscarin
- allosteric modulators
- substituted azacycles
- azacycles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201741042082 | 2017-11-23 | ||
| PCT/IB2018/059164 WO2019102365A1 (en) | 2017-11-23 | 2018-11-21 | Substituted azacycles as muscarinic m1 receptor positive allosteric modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3713940T3 true DK3713940T3 (da) | 2022-06-20 |
Family
ID=64744766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18822142.8T DK3713940T3 (da) | 2017-11-23 | 2018-11-21 | Substituerede azacykler som muscarin-m1-receptorpositive allosteriske modulatorer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20210369685A1 (da) |
| EP (1) | EP3713940B1 (da) |
| JP (1) | JP7034284B2 (da) |
| KR (1) | KR102443402B1 (da) |
| CN (1) | CN111386270B (da) |
| AU (1) | AU2018372664B2 (da) |
| BR (1) | BR112020010138A2 (da) |
| CA (1) | CA3082724C (da) |
| DK (1) | DK3713940T3 (da) |
| EA (1) | EA039902B1 (da) |
| HR (1) | HRP20220736T1 (da) |
| HU (1) | HUE058954T2 (da) |
| IL (1) | IL274708B (da) |
| MA (1) | MA50806A (da) |
| MX (1) | MX2020005341A (da) |
| NZ (1) | NZ764561A (da) |
| SG (1) | SG11202004580WA (da) |
| WO (1) | WO2019102365A1 (da) |
| ZA (1) | ZA202002938B (da) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697690B2 (en) | 2010-07-01 | 2014-04-15 | Merck Sharp & Dohme Corp. | Isoindolone M1 receptor positive allosteric modulators |
| EP2709451B1 (en) | 2011-05-17 | 2015-12-30 | Merck Sharp & Dohme Corp. | N-linked lactam m1 receptor positive allosteric modulators |
| CA2853826C (en) * | 2011-10-28 | 2021-03-23 | Vanderbilt University | Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| JP6517239B2 (ja) * | 2014-04-23 | 2019-05-22 | 武田薬品工業株式会社 | アルツハイマー病治療のためのコリン作動性ムスカリンｍ１受容体ポジティブアロステリックモジュレーター活性としてのイソインドリン−１−オン誘導体 |
| WO2017112719A1 (en) * | 2015-12-23 | 2017-06-29 | Merck Sharp & Dohme Corp. | 6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the m4 muscarinic acetylcholine receptor |
| WO2018005249A1 (en) * | 2016-06-28 | 2018-01-04 | Merck Sharp & Dohme Corp. | Benzoisoquinolinone m1 receptor positive allosteric modulators |
-
2018
- 2018-11-21 BR BR112020010138-9A patent/BR112020010138A2/pt unknown
- 2018-11-21 KR KR1020207017949A patent/KR102443402B1/ko active IP Right Grant
- 2018-11-21 CA CA3082724A patent/CA3082724C/en active Active
- 2018-11-21 SG SG11202004580WA patent/SG11202004580WA/en unknown
- 2018-11-21 AU AU2018372664A patent/AU2018372664B2/en active Active
- 2018-11-21 NZ NZ764561A patent/NZ764561A/en unknown
- 2018-11-21 MA MA050806A patent/MA50806A/fr unknown
- 2018-11-21 EP EP18822142.8A patent/EP3713940B1/en active Active
- 2018-11-21 HU HUE18822142A patent/HUE058954T2/hu unknown
- 2018-11-21 HR HRP20220736TT patent/HRP20220736T1/hr unknown
- 2018-11-21 CN CN201880075861.2A patent/CN111386270B/zh active Active
- 2018-11-21 EA EA202091302A patent/EA039902B1/ru unknown
- 2018-11-21 DK DK18822142.8T patent/DK3713940T3/da active
- 2018-11-21 JP JP2020528300A patent/JP7034284B2/ja active Active
- 2018-11-21 US US16/766,112 patent/US20210369685A1/en active Pending
- 2018-11-21 MX MX2020005341A patent/MX2020005341A/es unknown
- 2018-11-21 WO PCT/IB2018/059164 patent/WO2019102365A1/en unknown
-
2020
- 2020-05-17 IL IL274708A patent/IL274708B/en unknown
- 2020-05-20 ZA ZA2020/02938A patent/ZA202002938B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202002938B (en) | 2021-04-28 |
| SG11202004580WA (en) | 2020-06-29 |
| IL274708A (en) | 2020-07-30 |
| HRP20220736T1 (hr) | 2022-09-02 |
| MA50806A (fr) | 2020-09-30 |
| CA3082724C (en) | 2022-05-31 |
| BR112020010138A2 (pt) | 2020-11-10 |
| CN111386270A (zh) | 2020-07-07 |
| CA3082724A1 (en) | 2019-05-31 |
| IL274708B (en) | 2022-06-01 |
| WO2019102365A1 (en) | 2019-05-31 |
| KR20200090854A (ko) | 2020-07-29 |
| EP3713940A1 (en) | 2020-09-30 |
| AU2018372664B2 (en) | 2020-11-19 |
| NZ764561A (en) | 2021-12-24 |
| EA202091302A1 (ru) | 2020-08-17 |
| KR102443402B1 (ko) | 2022-09-15 |
| EA039902B1 (ru) | 2022-03-25 |
| JP2021504357A (ja) | 2021-02-15 |
| CN111386270B (zh) | 2022-05-03 |
| EP3713940B1 (en) | 2022-05-04 |
| HUE058954T2 (hu) | 2022-10-28 |
| AU2018372664A1 (en) | 2020-06-04 |
| US20210369685A1 (en) | 2021-12-02 |
| MX2020005341A (es) | 2020-08-13 |
| JP7034284B2 (ja) | 2022-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3774791T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| DK3394033T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| DK3294713T3 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3341367T3 (da) | Bicyklisk-fusionerede heteroaryl- eller arylforbindelser som irak4-modulatorer | |
| DK3131902T3 (da) | Forbindelser som ROR-gamma-modulatorer | |
| DK3472167T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| MA43382A (fr) | Modulateurs des récepteurs des chimiokines | |
| MA53943A (fr) | Modulateurs de ror-gamma | |
| ES2821790T8 (es) | Moduladores de la vía de estrés integrada | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| MA55328A (fr) | Modulateurs de ror-gamma | |
| DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3097107T3 (da) | Diaryl-makrocykler som modulatorer for proteinkinaser | |
| DK3331876T3 (da) | Modulators of ror-gamma | |
| DK3218392T3 (da) | Makrocykliske peptider, der er anvendelige som immunmodulatorer | |
| DK3105218T3 (da) | Cyclopropylaminer som lsd1-inhibitorer | |
| DK3105226T3 (da) | Cyclopropylaminer som lsd1-inhibitorer | |
| DK3743406T3 (da) | Tmem16a modulatorer | |
| DK3331863T3 (da) | Hidtil ukendte forbindelser som ror-gamma-modulatorer | |
| DK3357919T3 (da) | Aromatiske heterocykliske forbindelser som antiinflammatoriske forbindelser | |
| DK3359160T3 (da) | Farnesoid x receptor modulatorer | |
| DK3580220T3 (da) | Aminotriazolpyridiner som kinasehæmmere | |
| DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
| DK3377483T3 (da) | N-substituerede indolderivater som pge2-receptormodulatorer | |
| DK3490986T3 (da) | Piperidin-cxcr7-receptormodulatorer |